SMN2 and spinal muscular atrophy: Wang et al. investigated the mechanism underlying the effects of a small-molecule drug (RG-7916) in the treatment of spinal muscular atrophy and reported that KHSRP could bind to survival motor neuron 2 (SMN2) pre-mRNA and enhance SMN2 splicing [24].